Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: A randomized, double-blind, controlled equivalence drug trial

Rheumatology (United Kingdom)

Volumn 52, Issue 8, 2013, Pages 1408-1417

  Chopra, Arvind ^a   Saluja, Manjit ^a   Tillu, Girish ^b   Sarmukkaddam, Sanjeev ^c   Venugopalan, Anuradha ^a   Narsimulu, Gumdal ^d   Handa, Rohini ^e   Sumantran, Venil ^f   Raut, Ashwinikumar ^g   Bichile, Lata ^h   Joshi, Kalpana ^b   Patwardhan, Bhushan ^b  

^a Center for Rheumatic Diseases   (India)

^b SYMBIOSIS INTERNATIONAL UNIVERSITY   (India)

^c B J MEDICAL COLLEGE   (India)

^d NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^f Bharati Vidyapeeth Deemed University   (India)

^g SPARC Institute ^*  (India)

^h KEM HOSPITAL   (India)

Author keywords

Analgesics; Arthritis; Ayurvedic medicines; Chondroprotective agents; Drug trials; Equivalence drug trials; Ethnic medicine; Herbal drugs; Non steroidal anti inflammatory drugs (NSAIDs); Osteoarthritis

Indexed keywords

BOSWELLIA SERRATA EXTRACT; CELECOXIB; EMBLICA OFFICINALIS EXTRACT; GINGER EXTRACT; GLUCOSAMINE SULFATE; TINOSPORA CORDIFOLIA EXTRACT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; AYURVEDA; BODY WEIGHT; BOSWELLIA SERRATA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; EMBLICA OFFICINALIS; EPIGASTRIC DISCOMFORT; FEMALE; GINGER; HUMAN; KNEE OSTEOARTHRITIS; LIKERT SCALE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHARMACEUTICAL EQUIVALENCE; PHYSIOTHERAPY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN ULCER; TINOSPORA CORDIFOLIA; ULCER; VISUAL ANALOG SCALE; VOMITING; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

ANALGESICS; ARTHRITIS; AYURVEDIC MEDICINES; CHONDROPROTECTIVE AGENTS; DRUG TRIALS; EQUIVALENCE DRUG TRIALS; ETHNIC MEDICINE; HERBAL DRUGS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS); OSTEOARTHRITIS;

AGED; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GINGER; GLUCOSAMINE; HUMANS; INDIA; MALE; MEDICINE, AYURVEDIC; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PATIENT SELECTION; PLANT EXTRACTS; PYRAZOLES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TINOSPORA; TREATMENT OUTCOME;

EID: 84880604743     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes414     Document Type: Article

References (38)

1. The burden of musculoskeletal conditions at the start of the new millennium. Report of a WHO Scientific Group. WHO Technical Report Series 919. Geneva: WHO, 2003.
2. Joshi V, Chopra A. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model. J Rheumatol 2009;36:614-22.
3. Pendleton A, Arden N, Dougados M et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936-44.
4. Hochberg MC. Nutritional supplements for knee osteoarthritis-still no resolution. N Engl J Med 2006;354: 858-60.
5. Wandel S, Jüni P, Tendal B et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010;341:c4675.
6. Sharma PV. Caraka Samhita [English translation]. Delhi: Chaukhambia Orientalia, 1994.
7. Chopra A, Doiphode VV. Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med Clin North Am 2002;86:75-89.
8. Chopra A, Saluja M, Tillu G et al. A randomized controlled exploratory evaluation of standardized Ayurvedic formulations in symptomatic osteoarthritis knees: a Government of India NMITLI project. Evid Based Complement Alternat Med 2011;724291.
9. Brahmashankar M, ed. Bhavprakasha Nighantu. Vol. 1, 9th edn. Varanasi: Chaukhambha Sanskrit Sansthan, 1999, 212.
10. Gogate VM. Ayurvedic pharmacology and therapeutic uses of medicinal plants. Mumbai: Bhavan's SPARC, 2000.
11. Chopra A, Saluja M, Tillu G et al. Evaluating higher doses of Shunthi-Guduchi formulations for safety in treatment of Osteoarthritis knees: a Government of India NMITLI arthritis project. J Ayurveda Integr Med 2012;3: 51-7.
12. Sumantran V, Kulkarni A, Chandwaskar R et al. Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis. Evid Based Complement Alternat Med 2008;5:329-35.
13. Sumantran V, Joshi AK, Boddul S et al. Anti arthritic activity of a standardized, multiherbal, ayurvedic formulation containing Boswellia serrata: in vitro studies on knee cartilage from osteoarthritis patients. Phytother Res 2011;25: 1375-80.
14. OECD guidelines number 423. http://www.oecd.org/dataoecd/17/50/1948370.pdf (20 December 2012, date last accessed).
15. Chopra A. Rheumatology: made in India (Camps, COPCORD, HLA, Ayurveda, HAQ, WOMAC and drug trials). J Indian Rheum Assoc 2004;12:43-53.
16. Altman R, Asch E, Bloch G et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
17. Bellamy N. Musculoskeletal clinical metrology. Boston: Kluwer Academic, 1993.
18. Altman R, Brandt K, Hochberg M et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996;4:217-43.
19. Bellamy N, Goldsmith CH, Campbell J et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant measures to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15: 1833-40.
20. Chopra A, Lavin P, Patwardhan B et al. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug on osteoarthritis of the knees. J Clin Rheumatol 2004;10:236-45.
21. Tugwell P, Wells G, Shainhouse Z. Equivalence study of a topical diclofenac solution (Pennsaid-) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomised controlled trial. J Rheumatol 2004; 31:2002-12.
22. Jones B, Jarvis P, Lewis JA et al. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36-9.
23. Piaggio G, Elbourne DR, Altman DG et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295: 1152-60.
24. Garnero P, Ayral X, Rousseau JC et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteroarthritis. Arthritis Rheum 2002;46:2613-24.
25. Towheed TE, Maxwell L, Anastassiades TP et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005:CD002946.
26. Zhang W, Robertson J, Jones AC et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomized controlled trials. Ann Rheum Dis 2008;67: 1716-23.
27. Herrero-Beumont G, Ivorra JA, Del Carmen Trabado M et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double blind placebo controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007;56:555-67.
28. Guidance for Industry. Drug-induced liver injury: premarketing clinical evaluation. Washington, DC: Food and Drug Administration, July 2009. http://www.fda.gov/down loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdf (20 December 2012, date last accessed).
29. Andrade RJ, Robles M, Ferná ndez-Castañer A et al. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol 2007;13:329-40.
30. Chopra A. Ayurvedic medicine and arthritis. Rheum Dis Clin North Am 2000;26:133-44.
31. Kulkarni RR, Patki PS, Jog VP et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991;33:91-5.
32. Chopra A, Saluja M, Tillu G et al. Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clin Rheumatol 2011;31:259-69.
33. Vaidya AD, Devasagayam TP. Current status of herbal drugs in India: an overview. J Clin Biochem Nutr 2007;41: 1-11.
34. US FDA guidance to industry on botanical drug products. Beltsville, MD: Center for Drug Evaluation and Research, 2004.
35. Gagnier JJ, Boon H, Rochon P et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006;144: 364-7.
36. Clegg DO, Reda DJ, Harris CL et al. Glucosamine, chondroitin sulfate and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.
37. Chopra A, Anuradha V, Ghorpade R et al. Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 2012; 140:842-50.
38. Chopra A, Saluja M, Tillu G. Ayurveda-modern medicine interface: a critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis. J Ayurveda Integr Med 2010;1:190-8.